One Man Biotech Fund

因此,我的团队,包括我在内的四个人,正在探索我要管理的生物技术投资组合的想法。仅直接投资。我还是很新的asset management(第二年),我是一体主义者,尽管我确实有生命科学背景。

I don't think this is feasible atm. For one, nobody else understands this stuff aside from me, so I have a really hard time explaining why it takes so long to evaluate companies in this space (can't expect me to come up with a buy/pass conclusion in three days, maybe a week depending on the opportunity...or am I just incompetent?). This brings me to the next problem, which is diversification. We are fairly concentrated, but I can't replicate this in biotech. From my initial calculations, I would need 25-35 positions. The worry here is the amount of time needed for accumulating this many positions. Assuming I reject at least 9 out of every 10 companies I review, I would have to run through at least 200-300 biotechs to come up with enough ideas. The most feasible option to me seems to be focusing on companies with products that already cleared phase 3, but where the share price remains depressed due to unproven execution know-how.

I am considering excluding biotech altogether and instead adding medtech, services and the occasional big pharma that I can trust as a capital allocator.

Maybe I am wrong, maybe someone here has seen one-man shops delivering consistent returns in Biotech. Would love some perspective on how I could make this work.

Comments (1)

9mo
Journeytofreedom, what's your opinion? Comment below:

Repellat pariatur hic sed autem at. Ab inventore quia sapiente debitis. Exercitationem beatae veniam qui perferendis dolorum reiciendis maxime. Et fuga dolores in laborum doloribus et. Quos earum animi consectetur autem autem ratione reiciendis. Vero quia voluptates eveniet et saepe in qui. Sequi sed rerum sed perferendis doloremque inventore.

Et voluptatem vel et laboriosam. Quia quos aperiam et corporis. Id omnis recusandae praesentium non. Molestiae aspernatur corporis ut. Nemo pariatur aliquid possimus vitae labore velit exercitationem officia. Architecto aspernatur voluptatem molestias incidunt velit optio quis. Est aut repellat ipsa est aliquam.

Start Discussion

Popular ContentSee all

伦敦的AM场景是什么样的?
+19 AM byAnalyst 1 in IB - Gen
Understanding Macro
+18 AM bynordic_puts
Artisan Partners Comp/Info
+17 AM byInvestment Analyst in HF - EquityHedge
200K
+15 AM byInvestment Analyst in HF - Event
Individual Trading or Wealth management?
+14 AM bySummer Associate in AM - Equities

Career Advancement Opportunities

March 2023万博app网页版

  • Lazard Freres(+ +) 99.5%
  • Jefferies&Company(▽01) 99.1%
  • Financial Technology Partners(= =) 98.6%
  • Lincoln International(▽02) 98.2%
  • William Blair(▲10) 97.7%

Overall Employee Satisfaction

March 2023万博app网页版

  • William Blair(▲04) 99.5%
  • Canaccord Genuity(▲18) 99.1%
  • Lincoln International(▲10) 98.6%
  • Stephens Inc(▲10) 98.1%
  • Financial Technology Partners(▲04) 97.7%

Professional Growth Opportunities

March 2023万博app网页版

  • Financial Technology Partners(▲05) 99.5%
  • Lazard Freres(▲14) 99.1%
  • Lincoln International(= =) 98.6%
  • Jefferies&Company(▽03) 98.1%
  • William Blair(▲02) 97.7%

Total Avg Compensation

March 2023万博app网页版

  • Director/MD (6) $592
  • Vice President (26) $422
  • Associates (141) $ 260
  • 3rd+ Year Analyst (9) $194
  • 2nd Year Analyst (86) $170
  • 第一年分析师(263) $171
  • Intern/Summer Associate (45) $165
  • Intern/Summer Analyst (192) $92

LeaderboardSee all

1
redever's picture
redever
99.2
2
BankonBanking的图片
BankonBanking
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
pudding's picture
pudding
99.0
5
卡农's picture
卡农
99.0
6
GameTheory's picture
GameTheory
98.9
7
MidMarketMcLovin's picture
MidMarketMcLovin
98.9
8
Jamoldo's picture
Jamoldo
98.9
9
Secyh62's picture
Secyh62
98.9
10
CompBanker's picture
CompBanker
98.9